ARPO

Aerpio Pharmaceuticals Stock Price

2.22
0.15 (7.25%)
Upgrade to Real-Time
Regular Market
2.22

Low
0.9541

52 Week Range

High
3.32

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Aerpio Pharmaceuticals Inc ARPO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.15 7.25% 2.22 11:18:39
Open Price Low Price High Price Close Price Prev Close
2.08 2.06 2.3684 2.07
Bid Price Ask Price Spread News
2.22 2.23 0.01 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,123 1,324,783 $ 2.23 $ 2,958,520 - 0.9541 - 3.32
Last Trade Time Type Quantity Stock Price Currency
11:18:39 10 $ 2.22 USD

Period:

Draw Mode:

Aerpio Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 105.16M 47.37M 35.30M $ 15.00M $ -4.84M -0.10 -23.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 100.00k 1.60%

more financials information »

Aerpio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARPO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.022.36841.882.071,634,5980.209.9%
1 Month1.863.321.622.6915,943,6160.3619.35%
3 Months1.183.320.95412.2011,032,1961.0488.14%
6 Months1.313.320.95412.115,995,2640.9169.47%
1 Year1.513.320.95411.934,000,4280.7147.02%
3 Years4.184.250.421.781,654,783-1.96-46.89%
5 Years4.004.350.421.791,615,886-1.78-44.5%

Aerpio Pharmaceuticals Description

Aerpio Pharmaceuticals Inc is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The company's product razuprotafib is a small molecule Tie2 activator being developed for the topical ocular treatment of primary open-angle glaucoma. Other products under the pipeline are ARP-1536 and AKB-4924.


Your Recent History
NASDAQ
ARPO
Aerpio Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.